Antibody cocktail: US trials of new COVID-19 drug

On Thursday, June 11, Regeneron Pharmaceuticals announced the start of the first clinical trial of its experimental drug based on antibodies to coronavirus, writes CNBC. The “cocktail” of antibodies will be tested on four groups of volunteers. Two of them will receive the medicine to test it...

Many sick, few dead: Russian coronavirus statistics alerted WHO

The organization points out that the difference between the number of coronavirus cases and the low mortality rate from it in Russia looks “unusual.” The country's authorities have repeatedly denied manipulation of COVID-19 statistics, writes RBC. Director of the WHO Emergencies Program...

Travel and pandemic: which US states require 14-day self-isolation after entry

States are gradually starting to open, but this does not mean that everyone can freely come and go as they please. Which states still require mandatory compliance with 14-day self-isolation, says USA Today. The publication has collected updated information on states requiring or recommending ...

California businessman accused of major coronavirus test fraud

Authorities said his company had billed Medicare $ 69 million for optional and inappropriate testing for allergies and coronavirus, writes Fox Business. On June 9, the president of a medical technology company in Silicon Valley was accused of injecting into ...

Scientists called a blood group whose owners are less likely to get COVID-19

The study shows that one of the blood groups can provide its owners with some protection against the coronavirus, writes Fox News. In April, shortly after the outbreak of the pandemic, genetic testing firm 23andMe began using its systems to help scientists better understand how genetics ...

Coronavirus could be in Wuhan in the fall of 2019: satellite photos were studied in the USA

The coronavirus could have spread in the Chinese city of Wuhan in early autumn 2019. This is the conclusion reached by a group of researchers from Harvard and Boston universities. Their work is posted in the electronic repository of scientific publications at Harvard University. It has not yet been reviewed by others ...

More masks than jellyfish: how 'coronavirus' waste pollutes the ocean

An excess of discarded disposable masks and gloves is littering the seabed and washing up on beaches, The Guardian reports. Conservationists have warned that the coronavirus pandemic could cause a surge in ocean pollution - on top of the glut of plastic waste already threatening marine...

14 US states record new COVID-19 incidence rate

As New York, Illinois and other states with high rates of coronavirus infection gradually slow down and the country's former hotspots ease quarantines, some parts of the US where it was relatively quiet before are recording new case records ...

Surprise Accounts: What You Need to Know About COVID-19 Medical Insurance and Treatment

Since the onset of the COVID-19 pandemic, healthcare providers have faced a variety of challenges and have had to quickly respond to changes in laws and regulations affecting their operations. One of these changes is restrictions on so-called medical “surprise bills” for...

The first approved drug for COVID-19 begins to be used in Russia: what is known about it

Таблетки «Авифавир» планируют поставлять в больницы уже в июне, пишет «Лайфхакер». Первый российский препарат от коронавирусной болезни «Авифавир» получил одобрение Минздрава. Разработчик препарата обещает, что уже 11 июня отправит первые партии своего лекарства в больницы. Разбираемся, откуда взялись эти жёлтые…

420 - 430 of 488